A Win For Sunesis Pharmaceuticals, Inc.
Thu, Mar 04, 2021 at 05:33 PM
Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) soared at $5.32, a gain of 24.3%. The stock got featured on our News Catalysts scanner on Wed 24 Feb 21 at 04:49 PM in the 'MERGER' category. From Wed 17 Feb 21, the stock recorded 20.00% Up Days and 72.73% Green Days
The stock spiked on Wed 24 Feb 21 at $7.09 with a volume of 70M+.
About Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ)
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
Top 10 Gainers:
- POW (POW:NASDAQ), 100%
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 78.74%
- Super League Gaming, Inc. (SLGG:NASDAQ), 69.29%
- Allied Esports Entertainment Inc. (AESE:NASDAQ), 30.8%
- Severn Bancorp, Inc. (SVBI:NASDAQ), 27.69%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- Genius Brands International, Inc. (GNUS:NASDAQ), 23.57%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 22.02%
- Centennial Resource Development, Inc. (CDEV:NASDAQ), 16.59%
- Rimini Street, Inc. (RMNI:NASDAQ), 16.55%